Powerful ruby laser from the NanoStar® Family
The NanoStar® R ruby laser with a wavelength of 694 nm is the ideal choice for tattoo- and pigment removal. The ruby wavelength is the optimal wavelength for the removal of darker pigments such as black and blue. It is also effective in the treatment of green-colored tattoos. The ultra-short pulses of the Q-Switched technology make it possible to burst the particles without any thermal side effects or scars. This increases patient comfort. A lower penetration depth and higher melanin absorption makes removal of even deep melasma possible.
The NanoStar® Family comes in modern design and uses the well-known Q-Switched technology. The automatic spot detection allows different conditions on every part of the body to be treated in a fast, safe and efficient way.
Intuitive User Interface
- Big and clear 10.4 inch LCD touch screen
- Big buttons and symbols that are clearly visible
- Dark background for higher contrast und colour brilliance
- Clear lines and rounded edges, similar to designed device
- Variety of settings possible for maximum flexibility
New handpieces with innovative OptiBeam II technology
The NanoStar® Family comes with a variety of different flat-top and fractional handpieces. For this handpiece line, OptiBeam II technology was developed meaning the laser is able to produce a highly precise beam for the most detailed and clean work. The OPTIBEAM® handpieces assure a flat-top beam profile due to their advanced optical technology, able to distribute the laser power homogeneously over the treatment spot. The handpieces are available in squared or fractional round spot shapes (5×5 mm, 4×4 mm, 3×3 mm, 2×2 mm and 8 mm Ø, 9mm Ø), which allows to treat areas of any size.
Asclepion Laser Technologies is working closely with physicians, clinics and universities to improve technologies to assess their effectiveness and safety as well as to improve its application. In clinical studies, scientific questions are answered in a controlled environment. This ensures the best possible results for both the users and patients.